Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation

doi:10.5500/wjt.v14.i2.93567

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1646)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

HTML

859

Figures (1-2)

216

Tables (1-2)

192

Sum=1331

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

204

Sum=242

Jun 18, 2024 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Transplant. Jun 18, 2024; 14(2): 93567
Published online Jun 18, 2024. doi: 10.5500/wjt.v14.i2.93567

Full Size Figure Download Figure

Figure 2 Post-transplantation 1-year survival according to multidrug-resistant organism status. 1-year survival was 72% in heart transplant recipients with multidrug-resistant organism (MDRO) presence (MDRO+) vs 92% in MDRO-free (MDRO-) recipients (P < 0.01). MDRO: Multidrug-resistant organism.

Citation: Hatzianastasiou S, Vlachos P, Stravopodis G, Elaiopoulos D, Koukousli A, Papaparaskevas J, Chamogeorgakis T, Papadopoulos K, Soulele T, Chilidou D, Kolovou K, Gkouziouta A, Bonios M, Adamopoulos S, Dimopoulos S. Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation. World J Transplant 2024; 14(2): 93567
URL: https://www.wjgnet.com/2220-3230/full/v14/i2/93567.htm
DOI: https://dx.doi.org/10.5500/wjt.v14.i2.93567